A randomized trial of amifostine as a cytoprotective agent in patients receiving chemotherapy for small cell lung cancer

A randomized trial was conducted to determine whether administration of Amifostine with chemotherapy for small cell lung cancer could decrease the toxicity. 84 patients with small cell lung cancer of favourable prognosis (limited disease, performance status 0–1; limited disease with performance stat...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, P W M, Muers, M F, Peake, M D, Poulter, K M, Gurney, E M, Napp, V, Hepburn, P M, Brown, J M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363622/
https://www.ncbi.nlm.nih.gov/pubmed/11139307
http://dx.doi.org/10.1054/bjoc.2000.1539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363622/
https://www.ncbi.nlm.nih.gov/pubmed/11139307
http://dx.doi.org/10.1054/bjoc.2000.1539

Ejemplares similares